Nothing Ventured, Everything Gained
Article Abstract:
Some investors and industry experts are enraged by a new hedging strategy which the Perry Corporation used to acquire shares in Mylan Laboratories without entailing any financial risk, putting it in a position to influence an acquisition attempt of King Pharmaceuticals.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Amid Duel for MCI, Shareholder Resentment
Article Abstract:
Verizon Communications' plan to buy Carlos Slim Helu's 13.4 percent stake in MCI may have angered shareholders because it gives the company a voting advantage over rival bidder Qwest Communications.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Loewen group's founder steps down from board. Northern B.C. ports square off over proposed pipeline. At 74, Jimmy Pattison focuses on long term
- Abstracts: GM's mortgage unit deal brings in $9-billion. Stelco signals it intends to go it alone
- Abstracts: Amaranth managed to trample the most revered investing principles. MDS board adds hedge fund manager; may be first step to revamp
- Abstracts: For G.O.P., It's a Moment. Clinton Seeking Shared Ground Over Abortions. Strong Charges Set New Tone Before Debate
- Abstracts: The Bounceback Year. With Defaults Down, Banks and Bond Markets Find Nothing to Fear. Grasping at the Statistics on the Self-Employed